L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
Clinical trial NCT02891837 · COMPLETED
Trial details
- NCT number
- NCT02891837
- Sponsor
- Asklepion Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2019-06-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.